Fast Tracked Reviews and Complaints First, the drug must be intended to treat a serious condition, which the FDA defines broadly as a disease or condition associated with morbidity that substantially impacts day-to-day functioning, or one that, if left untreated, will progress in severity or affect survival. The second criterion for being Fast Tracked is that the drug must demonstrate the potential to address an unmet medical need, which means there is no existing therapy for the condition, or the new drug offers a significant advantage over what's already available. The key thing to understand about getting Fast Tracked is that the FDA doesn't require clinical data to grant the designation — you can request Fast Tracked status based on nonclinical data, mechanistic rationale, or even just a strong scientific argument that your drug has the potential to fill a gap in treatment.
Fast Tracked Reviews and Complaints First, the drug must be intended to treat a serious condition, which the FDA defines broadly as a disease or condition associated with morbidity that substantially impacts day-to-day functioning, or one that, if left untreated, will progress in severity or affect survival. The second criterion for being Fast Tracked is that the drug must demonstrate the potential to address an unmet medical need, which means there is no existing therapy for the condition, or the new drug offers a significant advantage over what's already available. That advantage could take many forms — it might be superior effectiveness, a better safety profile, improved convenience for patients, or the ability to treat a subset of patients who don't respond to current treatments. Order Now Fast Tracked Where to Buy